Alpha Tau Medical Presents Overall Survival, Safety Results From Pooled Analysis Of Three Prospective Phase I/II Clinical Studies Evaluating EUS-Guided Intratumoral Alpha Dart Treatment In PDAC Patients At 2026 ASCO Annual Meeting

Loading news article.

Alpha Tau Medical Presents Overall Survival, Safety Results From Pooled Analysis Of Three Prospective Phase I/II Clinical Studies Evaluating EUS-Guided Intratumoral Alpha Dart Treatment In PDAC Patients At 2026 ASCO Annual Meeting | WAPE

Alpha Tau Medical Presents Overall Survival, Safety Results From Pooled Analysis Of Three Prospective Phase I/II Clinical Studies Evaluating EUS-Guided Intratumoral Alpha Dart Treatment In PDAC Patients At 2026 ASCO Annual Meeting

Article summary

Related companies

Comments —